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Abstract This review is focused on ankyrin which is a protein
linker between the integral membrane proteins and spectrin-
based cytoskeleton. Structure and distribution of different
ankyrin isoforms that are products of alternative-spliced genes
are described. Interaction of ankyrins with various membranes is
considered. Special attention is paid to ankyrin participation in
signal transduction and in assembly of integral membrane
proteins in specialized membrane domains. ß 2000 Federation
of European Biochemical Societies. Published by Elsevier Sci-
ence B.V. All rights reserved.
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1. Introduction
The membrane-associated cytoskeleton is a two-dimension-
al network located on the cytoplasmic surface of the plasma
membrane [1,2]. It is built up mainly by £exible rod-shaped
molecules of spectrin (or its analogue fodrin) that are joined
by ends to form ¢ve- or six-sided polygons (Fig. 1A). The
corners of polygons consist of short actin ¢laments. Mem-
brane cytoskeleton is crucial to maintain the shape of the cells
and to restrict the lateral di¡usion of integral membrane pro-
teins. The cytoskeleton is attached to the plasma membrane
through vertical interactions involving ankyrin (Fig. 1B). An-
kyrin isoforms appear to provide also the linkage between the
cytoskeleton and the membranes of intracellular organelles.
However, ankyrin is not a simple linker: it is also involved
in the signal transduction and protein sorting.
2. Ankyrin isoforms
Ankyrins are a family of proteins that possess binding sites
for di¡erent integral membrane proteins as well as for cyto-
skeleton proteins. Molecular cloning has identi¢ed three dis-
tinct genes encoding ankyrins (ANK1, ANK2 and ANK3)
that are expressed as tissue speci¢c alternatively spliced iso-
forms. Corresponding polypeptides are designated as Ank1
(ankyrin R), Ank2 (ankyrin B), and Ank3 (ankyrin G).
Ankyrins R and B with molecular weight (Mr) 206 and 220
kDa, respectively, are the best characterized members of the
family. These isoforms share a similar domain structure [3].
They contain three domains: N-terminal or membrane-bind-
ing, central spectrin/fodrin-binding, and C-terminal regulatory
domains (Fig. 1C).
The membrane-binding domain consists for 30% of K-helix
[4]. It is formed by 24 tandemly organized repeat motifs (an-
kyrin repeats), each of them made up of 33 amino acids [1,3].
The membrane-binding domain has a globular shape and is
formed by four independently folded sub-domains of six re-
peats each [5].
The spectrin-binding domain contains three sub-domains
[6]. The N-terminal sub-domain is enriched in proline and
acidic amino acids. The central sub-domain contains mainly
basic amino acids and the C-terminal sub-domain is neutral.
The ¢rst two sub-domains are highly conserved between an-
kyrins B and R while the acidic region is variable [3].
The regulatory domain is very acidic and sensitive to pro-
teolysis [7,8]. It modulates a⁄nities of both spectrin- and
membrane-binding domains to target proteins [9].
Ankyrins are present as a set of isoforms in a number of
tissues. The major ankyrin in human erythrocytes is ankyrin
R with a Mr of about 206 kDa (protein band 2.1). Ankyrins
with Mr 186, 170, and 145 kDa are presented in a smaller
amount [1]. Most of the ankyrin isoforms result from alter-
native splicing, however some of them (for example, 170-kDa
ankyrin) may be proteolytic fragments of ankyrins with a
higher Mr [9].
Ankyrin R is subjected to modi¢cation by alternative splic-
ing at sites located in the regulatory domain [3,8,10]. The 186-
kDa ankyrin R (protein band 2.2) results from the deletion of
162 amino acids in the regulatory domain (Fig. 2). It has
higher a⁄nity to ankyrin-binding proteins than 206-kDa an-
kyrin R [3].
In addition to erythrocytes, ankyrin R is expressed in
muscles [11], macrophages [12], endothelial cells [13], in gran-
ule and Purkinje cells of the cerebellum, in neurons of the
spinal cord and hippocampus [14,15].
Small ankyrins R (20^26 kDa) are alternatively spliced iso-
forms produced by the ANK1 gene [16,17]. They are localized
in the region M and Z lines of skeletal myo¢brils enriched in
the sarcoplasmic reticulum. These ankyrins lack both the
membrane- and spectrin-binding domains and the C-terminal
domain is signi¢cantly shortened (the last 82 amino acids are
retained). The N-terminal part of these ankyrins contains a
unique highly hydrophobic structure including 72 amino acids
forming a membrane-protruding helix (Fig. 2).
Ankyrins B are presented mainly in nervous tissue. 440-kDa
ankyrin B contains a 220-kDa rod-shaped domain inserted
between C-terminal and spectrin-binding domains (Fig. 2).
This isoform is expressed in unmyelinated axons and dendrites
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of embryonic brain [18]. The 220-kDa ankyrin B with a do-
main organization similar to those of ankyrin R (Fig. 2) is
expressed in cell bodies and dendrites of neurons and in glia
[19].
The ANK3 gene encodes isoforms that are presented in
many tissues. Ankyrins G are main ankyrin forms in epithelial
cells, myocytes, hepatocytes, megakaryocytes, and neurons
[20]. In brain the 190-, 270- and 480-kDa ankyrins G are
found: the 190-kDa isoform is abundant in unmyelinated ax-
ons, 270- and 480-kDa isoforms are localized in the nodes of
Ranvier and in the initial segments of myelinated axons
[21,22].
A molecule of the 480-kDa ankyrin G consists of the glob-
ular (membrane- and spectrin-binding domains) and the ex-
tended regulatory parts (Fig. 2). A unique 46-kDa fragment
enriched in serine and threonine is inserted between the spec-
trin-binding domain and the terminal part of the 480- and
270-kDa ankyrin G molecules (Fig. 2). This fragment is gly-
cosylated, and glycosylation seems to be responsible for the
speci¢c localization of these isoforms [21].
Ankyrin G with a Mr of about 190 kDa expressed in kidney
contains a N-terminal unique fragment (31 amino acid resi-
dues), membrane-and spectrin-binding domains, and trun-
cated regulatory domains (Fig. 2) [23]. Four isoforms of an-
kyrin G are expressed in kidney: 215- and 200-kDa isoforms
are concentrated mainly in proximal cells, 170- and 120-kDa
isoforms- in distal tubular cells of the inner medulla [24].
The 119-kDa ankyrin G expressed in epithelium and
muscles associates with the Golgi apparatus, other small iso-
forms of ankyrin G (100^120-kDa) are linked with lysosomes
[25,26] and the sarcoplasmic reticulum in the region of the Z
lines [27]. The 100^120-kDa ankyrins G that are found in
colon, kidney, and testis lack the membrane-binding domain
and its regulatory domain is shortened to 29 amino acid res-
idues (Fig. 2B) [12].
3. Interaction of ankyrin with cytoskeleton proteins
A molecule of spectrin consists of two extended K- and
L-subunits that twist about each other forming a helix with
length of about 200 nm (Fig. 1) [28]. One ankyrin molecule is
bound to one L-subunit of the spectrin heterotetramer provid-
ing a major membrane attachment of cytoskeleton network.
Spectrin interacts with the N-terminal part of the spectrin-
binding domain: proteolytic fragments of ankyrin missing
the ¢rst 80 amino acid residues of this domain lose spectrin-
binding activity [29].
Ankyrin can bind also to the protein of intermediary ¢la-
ments vimentin [30] as well as to tubulin of microtubules [31].
Thus, ankyrin seems to participate in the attachment of the
intermediary ¢laments and microtubules to the membrane.
4. Interaction of ankyrin with membrane proteins
Ankyrin interacts with cytoplasmic domains of several in-
tegral membrane proteins. Mainly membrane-binding domain
Fig. 1. Schematic models showing the organization of spectrin-based cytoskeleton (A), attachment of integral membrane protein (band 3) to a
spectrin molecule mediated by ankyrin (B), and the domain structure of the ankyrin R molecule. Based on the ¢gures presented in reviews [2]
and [3].
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of ankyrin participates in the binding. However, in some cases
spectrin-binding [32] and regulatory domains are involved in
the interaction with the membrane proteins, it is mainly char-
acteristic for ankyrin G [33]. One ankyrin molecule is able to
bind several various membrane proteins providing assembly
of integral membrane proteins into specialized regions of the
plasma membrane [34].
4.1. Protein 3
HCO3/Cl exchanger is a major site of ankyrin binding in
erythrocyte membrane. Membrane-binding domain of ankyrin
R has two binding sites for protein 3 [35]. The binding of
ankyrin with the ¢rst site is due mainly to electrostatic forces
and with the second site mainly to non-ionic interactions.
Ankyrin binding induces the oligomerization of protein 3
[36]. About 40% of all molecules of protein 3 in erythrocytes
are characterized by restricted rotational mobility that ap-
pears to be the result of their association with the cytoskele-
ton.
Ankyrin binds to protein 3 when it is still in endoplasmic
reticulum or in the ¢rst compartment of the Golgi apparatus
and ankyrin seems to be responsible for the exit of this com-
plex from the Golgi apparatus [37].
4.2. Na-channels
Amiloride-sensitive Na-channels are co-localized in brush
border of kidney epithelium with ankyrin, fodrin, and actin.
Ankyrin binds to the 150-kDa subunit of the channel. Lateral
mobility of Na-channels is restricted due to the interaction
with membrane cytoskeleton [38].
Voltage-dependent Na-channels are concentrated in the ini-
tial segments of neurons, nodes of Ranvier, and in postsynap-
tic folds of neuromuscle junctions together with ankyrin G
and spectrin [39]. Subunits L1 and L2 of voltage-sensitive
Na-channels that are members of the immunoglobulin super-
family interact during cell adhesion inducing recruitment of
ankyrin to the region of cell contacts [40].
4.3. Na,K-ATPase
Polarized localization of Na,K-ATPase in a certain part of
plasma membrane (basal or apical) determines the direction of
ionic transport through the epithelial layer. Na,K-ATPase is
concentrated in the apical membrane of choroid plexus (secre-
tory epithelium of brain ventricles) and retinal pigment epi-
thelial cells. In kidney and salivary glands epithelial cells it
is localized in the basal part of membrane. Speci¢c localiza-
tion of Na,K-ATPase in the plasma membrane of these epi-
thelia is due to its interaction with the cytoskeleton elements
[41^44].
Ankyrin binds to Na,K-ATPase with high a⁄nity. There
are two binding sites on the ankyrin molecule: one is within
the membrane-binding and another one within the spectrin-
binding domain [45]. There are also two binding sites for
ankyrin on cytoplasmic domain of the K-subunit of Na,K-
ATPase [32]. A site possessing higher a⁄nity is formed by
the peptide located between 142 and 166 amino acid resi-
dues.
It is known that the L-subunit of Na,K-ATPase has a large
extracellular glycosylated domain. The L-subunit was identi-
¢ed as adhesion molecule [46]. Thus, Na,K-ATPase can simul-
taneously interact with the cytoskeleton and participate in the
cell contacts. One can suggest that ankyrin binding to Na,K-
ATPase or the involvement of Na,K-ATPase L-subunit in cell
adhesion contact may also a¡ect the activity of this pump.
4.4. Receptors
Ankyrin with high a⁄nity and speci¢city binds to the
500-kDa ryanodine receptor (RyR) of T-lymphoma cells, skel-
etal muscles, heart, and brain. Ankyrin-binding sites of RyR
are highly conserved [47]. There is evidence that the cytoskel-
eton plays a pivotal role in the regulation of RyR-mediated
Ca2 release during T-lymphocyte activation [48].
Inositol 1,4,5-triphosphate receptor (IP3R) located in the
membrane of calciosomes of T-lymphoma cells and brain
binds ankyrin R inhibiting IP3-induced Ca2 release [49].
IP3R and ankyrin are co-localized after forming of receptor
clusters as a result of the action of di¡erent ligands. Therefore
ankyrin binding with IP3R appears to play a key role in the
control of Ca2 release mediated by IP3R. The amino acid
sequence of the ankyrin-binding site in IP3R shares signi¢cant
homology with these sites in other ankyrin-binding proteins
(in particular, in hyaluronate receptor CD44) [49].
CD44 providing the cell interaction with extracellular ma-
trix (collagen, ¢bronectin) binds ankyrin after the formation
of patched structures of CD44 molecules in the membrane
and this binding is necessary for signal transduction mediated
by CD44 [50]. The ankyrin-binding site of CD44 is presented
by a peptide consisting of 15 amino acids and located within
the cytoplasmic domain [51]. Phosphorylation, acylation, and
GTP binding to CD44 [52] activate ankyrin binding. Interac-
tion of CD44 with ankyrin plays an important role in can-
cerogenesis [51,52].
Fig. 2. Domain structure of ankyrin isoforms. M ^ membrane-bind-
ing domain; S ^ spectrin-binding domain; A ^ extended rod-shaped
domain; T ^ threonine and serine enriched domain; R ^ regulatory
domain.
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4.5. Protein kinase C (PKC)
Ankyrin, spectrin, and the L-subunit of PKC are co-local-
ized in T-lymphocytes. PKC activation induces rapid accumu-
lation of ankyrin, spectrin and PKC L-subunit in the cyto-
plasm as a single complex. T-lymphocyte treatment by PKC
inhibitors results in coordinated movement of ankyrin, spec-
trin and PKC L-subunit to the membrane [53].
4.6. Cell adhesion proteins
Cell adhesion proteins of L1-family (L1, CHL1, neurofas-
cin, Nr-CAM, and Ng-CAM) are the members of immuno-
globulin superfamily. These molecules mediate cell adhesion
that is required for neurite outgrowth, formation of axons,
and speci¢c growth cone guidance. The C-terminal part of
the cytoplasmic domain of L1-molecules speci¢cally binds an-
kyrin. The ankyrin-binding site is the most conserved region
and does not share homology with any known ankyrin-bind-
ing protein [54]. Cell adhesion mediated by L1-CAM induces
ankyrin recruitment in the region of cell contacts [55]. Within
the ankyrin-binding site of neurofascin the tyrosine residue is
located. The phosphorylation of this tyrosine prevents ankyr-
in binding and induces the dissociation of cell contacts [56].
Comparison of the structures of minimal ankyrin-binding sites
of CD44, neurofascin, IP3R and Na, K-ATPase reveals that
ankyrin binding with these proteins is due to the interaction of
ankyrin repeats with the loops consisting of 5^7 hydrophilic
amino acid residues [57].
5. Ankyrin repeats
Conserved repeats forming the membrane-binding domain
of ankyrin have in general the following sequence [1,7] :
-GXTPLHXAAXXGHXXXV/AXXLLXX GAXXN/DXXX-
X-. Fifteen amino acid residues in these repeats are highly
conserved and the others are variable in di¡erent repeats
and ankyrin isoforms [1].
The ankyrin repeat has an L-shaped structure consisting of
two K-helices following the L-hairpin loop [58]. Multiple re-
peats create a core inside which K-helices are concentrated.
This core is stabilized by helix^helix interactions. The L-hair-
pins that create potential surfaces for interactions with the
target proteins are exposed to the solvent (Fig. 3). The struc-
ture is stabilized by extended anti-parallel L-sheets formed
between the repeats and by hydrophobic bonds inside the
repeat and between the neighboring repeats. The speci¢c fea-
ture of this structure is the array of potential binding sites
created by exposed tips of L-hairpins. The sequence of this
region is mostly variable.
Ankyrin repeats are identi¢ed in the hundreds of proteins
that are found in prokaryotes and eukaryotes. In the list of
these proteins are channels, enzymes, toxins, transcription fac-
tors [1], tankyrase, a poly(ADP-ribose) polymerase that is a
negative regulator of telomere length maintenance [59], multi-
ple proteins involved in signal transduction, in particular, in-
tegrin-linked kinases [60], inhibitors of cyclin-dependent ki-
nases [61], death-associated protein kinase involved in
apoptosis [62], and many others. This suggests that ankyrin
repeats as many other conserved domains with the speci¢c
secondary structure (WD-repeats, pleckstrin homology do-
main, SH2- and SH3-domains) were created in the evolution
as an universal module mediating the protein^protein interac-
tions.
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